Ignite Creation Date:
2024-05-06 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05339217
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2022-04-02
Brief Title:
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
Sponsor:
Liu Tian
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
Peking2022SLE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Liu Tian
Lead Sponsor Class:
OTHER
Responsible Party:
Liu Tian
Responsible Party Title:
associate professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Peking University Peoples Hospital
Old Name:
None
Old Organization:
None